AHS 2022 | The NIH roadmap for headache research

Michael Oshinsky, PhD, National Institutes of Health (NIH), Bethesda, MD, discusses the NIH roadmap for migraine research. The NIH is committed to providing the funds and framework for researchers to investigate and contribute toward therapeutic development and further understand the biology of migraine and other headache disorders. The NIH roadmap is an invaluable tool for all headache research; with the roadmap in place, individuals suffering from the spectrum of headache disorders can experience a better quality of life. This interview took place at the 2022 American Headache Society (AHS) Annual Scientific Meeting in Denver, CO.